Anshan Hifichem Co., Ltd. Share Price

Equities

300758

CNE100003JV6

Specialty Chemicals

End-of-day quote Shenzhen S.E. 03:30:00 26/04/2024 am IST 5-day change 1st Jan Change
9.98 CNY +1.84% Intraday chart for Anshan Hifichem Co., Ltd. +8.24% -1.29%

Financials

Sales 2024 * 1.38B 191M 15.89B Sales 2025 * 1.55B 214M 17.82B Capitalization 4B 553M 46.07B
Net income 2024 * 79M 10.9M 909M Net income 2025 * 136M 18.77M 1.56B EV / Sales 2024 * 2.9 x
Net cash position 2024 * - 0 0 Net cash position 2025 * - 0 0 EV / Sales 2025 * 2.58 x
P/E ratio 2024 *
49.9 x
P/E ratio 2025 *
30.2 x
Employees 1,828
Yield 2024 *
-
Yield 2025 *
-
Free-Float 39.3%
More Fundamentals * Assessed data
Dynamic Chart
Anshan Hifichem Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Anshan Hifichem Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Anshan Hifichem Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Anshan Hifichem Co., Ltd.(XSEC:300758) added to S&P Global BMI Index CI
Anshan Hifichem Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Liaoning Xinda Project Management Center along with Huang Wei Shan,Duan Wenyong,Zhang Ying,Liang Xudong,Sun Donzhou,Li Zhongwei,Chen Xuanzhe,Zhang Huan,Zhao Bin,Hou Rongsheng,Gao Ying,Lu Peng,Xu Yan,Wang Pan, Zhang Huining, Xing Jun, Wang Baobing, Wei Jiwu, CuiYan, Zhou Hong, Liu Lian, Li Jian and Gao Dan signed an agreement to acquire shares worth 7.5% stake of Liaoning Meicai New Material Co., Ltd. from Anshan Hifichem Co., Ltd for CNY 0. CI
Anshan Hifichem Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Tranche Update on Anshan Hifichem Co., Ltd.'s Equity Buyback Plan announced on March 14, 2022. CI
Liaoning Meicai New Material Co., Ltd. signed Investment Framework Agreement to acquire Anshan HOP Technology Co.Ltd. CI
Anshan Hifichem Co., Ltd.'s Equity Buyback announced on March 14, 2022, has expired with 6,922,964 shares, representing 1.70% for CNY 78.99 million. CI
Liaoning Xingkong Sodium Battery Co., Ltd. announced that it expects to receive CNY 125 million in funding from Anshan Hifichem Co., Ltd., Malion New Materials Co., Ltd. CI
Liaoning Meicai New Material Co., Ltd. announced that it expects to receive CNY 750 million in funding from Anshan Hifichem Co., Ltd., Malion New Materials Co., Ltd. CI
Tranche Update on Anshan Hifichem Co., Ltd.'s Equity Buyback Plan announced on March 14, 2022. CI
Malion New Materials Forms Prussian Blue Production JV With Anshan Hifichem MT
Anshan Hifichem Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
More news
1 day+1.84%
1 week+8.24%
Current month+20.24%
1 month+23.98%
3 months+13.80%
6 months-1.09%
Current year-1.29%
More quotes
1 week
8.77
Extreme 8.77
10.25
1 month
8.00
Extreme 8
11.89
Current year
5.37
Extreme 5.37
11.89
1 year
5.37
Extreme 5.37
12.00
3 years
5.37
Extreme 5.37
18.65
5 years
5.37
Extreme 5.37
22.35
10 years
5.37
Extreme 5.37
22.35
More quotes
Managers TitleAgeSince
Chief Executive Officer 53 01/06/01
Director of Finance/CFO 42 01/21/01
Chief Tech/Sci/R&D Officer 58 01/06/01
Members of the board TitleAgeSince
Director/Board Member 55 22/17/22
Chief Executive Officer 53 01/06/01
Chief Tech/Sci/R&D Officer 58 01/06/01
More insiders
Date Price Change Volume
26/24/26 9.98 +1.84% 29,394,610
25/24/25 9.8 +4.81% 28,575,700
24/24/24 9.35 +0.32% 16,571,800
23/24/23 9.32 +3.21% 20,979,980
22/24/22 9.03 -2.06% 15,832,000

End-of-day quote Shenzhen S.E., April 26, 2024

More quotes
Anshan Hifichem Co., Ltd. is a China-based company mainly engaged in research and development, production and sales of high performance organic pigments. The Company's products mainly include high-performance organic pigment series, solvent dye series, intermediate series products and others. These products are mainly used in coatings, plastics and ink areas. The Company mainly conducts its businesses in domestic market.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
9.98
Average target price
-
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 300758 Stock